Your browser doesn't support javascript.
loading
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.
Qiu, Xintao; Brown, Lisha G; Conner, Jennifer L; Nguyen, Holly M; Boufaied, Nadia; Abou Alaiwi, Sarah; Seo, Ji-Heui; El Zarif, Talal; Bell, Connor; O'Connor, Edward; Hanratty, Brian; Pomerantz, Mark; Freedman, Matthew L; Brown, Myles; Haffner, Michael C; Nelson, Peter S; Feng, Felix Y; Labbé, David P; Long, Henry W; Corey, Eva.
Afiliação
  • Qiu X; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Brown LG; Department of Urology, University of Washington, Seattle, Washington, USA.
  • Conner JL; Department of Urology, University of Washington, Seattle, Washington, USA.
  • Nguyen HM; Department of Urology, University of Washington, Seattle, Washington, USA.
  • Boufaied N; Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
  • Abou Alaiwi S; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Seo JH; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • El Zarif T; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Bell C; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • O'Connor E; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Hanratty B; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Pomerantz M; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Freedman ML; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Brown M; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Haffner MC; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Feng FY; University of California at San Francisco, San Francisco, California, USA.
  • Labbé DP; Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
  • Long HW; Department of Surgery, Division of Urology, McGill University, Montréal, Québec, Canada.
  • Corey E; Center for Functional Cancer Epigenetics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
JCI Insight ; 7(10)2022 05 23.
Article em En | MEDLINE | ID: mdl-35603787
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos